v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Cash $ 827,366 $ 2,401,831
Digital Assets (Note 2) 11,651,969 3,416,256
Finance receivables 27,459 19,221
Marketable securities (Note 5) 15,700 17,860
Receivable from sale of Symbiont assets (Note 5) 200,000 200,000
Prepaid expenses and other assets 2,483,368 4,067,212
Income tax receivable 31,187 31,187
Current assets 15,237,049 10,153,567
Fixed assets, net (Note 3) 20,897,314 24,519,610
Deposits on mining equipment (Note 4) 1,117,798 20,837
Notes receivable from Seastar Medical Holding Corporation (Note 5)   1,440,498
Long-term investments - equity securities (Note 5) 753,973 156,992
Investment in Seastar Medical Holding Corporation (Note 5) $ 1,899,484 $ 1,145,486
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Operating lease - right of use assets (Note 7) $ 162,966 $ 189,009
Other assets 86,798 86,798
Long-term assets 24,918,333 27,559,230
Total assets 40,155,382 37,712,797
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 2,042,906 2,064,909
Note payable - short-term (Note 6) 325,669 567,586
Due to related parties (Note 10) $ 55,290 $ 22,845
Other Liability, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 7) $ 114,148 $ 110,384
Total current liabilities 2,538,013 2,765,724
Lease liability - net of current portion (Note 7) 56,148 85,775
Long-term liabilities 56,148 85,775
Total liabilities 2,594,161 2,851,499
Stockholders' equity (Note 9)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common stock, par value $.001; 350,000,000 shares authorized; 2,492,964 shares issued and outstanding as of March 31, 2024 and 2,492,964 as of December 31, 2023 2,493 2,493
Additional paid-in capital 95,327,227 95,145,376
Accumulated deficit (56,857,610) (58,961,461)
Total LM Funding America stockholders' equity 38,472,110 36,186,408
Non-controlling interest (910,889) (1,325,110)
Total stockholders’ equity 37,561,221 34,861,298
Total liabilities and stockholders’ equity $ 40,155,382 $ 37,712,797

Source

HTML PDF
ZIP